Скачать с ютуб Urgent Need for Diversity and Inclusion in Myeloma Clinical Trials | Why I Flew to Maui for 24 Hours в хорошем качестве

Urgent Need for Diversity and Inclusion in Myeloma Clinical Trials | Why I Flew to Maui for 24 Hours

Dr. Joseph Mikhael, Chief Medical Officer at the International Myeloma Foundation (IMF), discusses the critical issue of diversity and inclusion in myeloma clinical trials. Read Dr. Joe's blog about the DRIVE initiative here: https://www.myeloma.org/blog/signing-... Key points covered in this video: The Maui Declaration: A commitment by myeloma and lymphoma doctors to increase diversity in clinical trials. The DRIVE Initiative: Advocating for Diversity Officers in clinical trials to ensure fair representation. The importance of clinical trials for accessing new myeloma treatments. Lack of diversity in trials: African Americans and other minorities are underrepresented. The Maui Declaration: A call to action for wider adoption of diversity practices. Collaboration with National Institutes of Health (NIH) and National Cancer Institute (NCI) to address the issue. _______________ Improving Lives | Finding the Cure Founded in 1990, the International Myeloma Foundation (IMF) is the first and largest organization focusing specifically on multiple myeloma. The IMF’s reach extends to more than 525,000 members in 140 countries worldwide. The IMF is dedicated to improving the quality of lives of myeloma patients while working toward prevention and a cure through our four founding principles: Research, Education, Support, and Advocacy. Subscribe to our channel:    / imfmyeloma   Visit our website at: https://www.myeloma.org Find us online: Facebook: @myeloma |   / myeloma   X/Twitter: @IMFMyeloma |   / imfmyeloma   Instagram: @imfmyeloma |   / imfmyeloma   LinkedIn:   / international-myeloma-foundation   Support the IMF | Donate Now! https://fundraise.myeloma.org/give/52... Category Nonprofits & Activism License Standard YouTube License In most cases, captions are autogenerated by YouTube.